- Author(s):
- Organization(s):
Aptar Pharma
Electronic devices in nasal aerosols can improve patient compliance and meet user needs while driving down healthcare costs.
Nasal sprays are now showing great promise in the delivery of drugs for breakthrough pain relief and vaccines. Innovation is set to continue as electronic “smart” devices are being integrated into designs in order to increase patient compliance, a key market driver for nasal aerosols.